Healthy.io, Geisinger and Boehringer Ingelheim Reveal Milestone Data at AHA 2024
The collaboration's research demonstrates how smartphone technology achieved a 2.5x increase in testing rates, offering a promising solution for early...
Pharmaceutical
Study Shows Ubie Symptom Checker Accuracy Rivals Physicians, Outperforms Competitors In Providing Disease Information
Results show Ubie's differential diagnosis platform had a Top-5 hit accuracy of 63.4% and a Top-10 hit accuracy of 71.6%;...
Qualifyze Raises $54m to Boost Supplier Risk Management in Life Sciences
FRANKFURT, Germany, Sept. 10, 2024 /PRNewswire/ -- Qualifyze, a trusted company in supplier risk management in the Life Sciences industry,...
Doceree launches first-ever HCP-only Data Marketplace at DPE 2024
Addressing the persistent challenges encountered by both marketers and data partners, Doceree introduces MarketplaceThe innovative solution empowers precision-driven nudging with...
PharmaForceIQ Announces Majority Investment by Eir Partners to Support and Accelerate Growth
MIAMI, Sept. 10, 2024 /PRNewswire/ -- PharmaForceIQ (PFIQ), the leading end to end Omnichannel Solution for Pharmaceutical Marketing, Medical and...
Aquila Solutions Launches Altair
WARNER ROBINS, Ga., Sept. 10, 2024 /PRNewswire/ -- Aquila Solutions, a leader in regulatory and pharmaceutical management consulting, proudly announces...
Cognition Corporation Launches Compass MED: A Revolutionary Solution to Simplify and Accelerate Medical Device Development
As medical devices become increasingly more complex, the need to enhance development efficiency, quality by design, integrated risk management, and...
DeepIntent and Everyday Health Group Partner to Offer Exclusive Access to Premium Health Segments and Advanced Targeting
The partnership enhances DeepIntent's platform with premium, first-look media offerings and provides Everyday Health Group with an advanced DSP platform...
Slope Launches Tech-Enabled Services to Bolster Biospecimen Lifecycle Management in Clinical Trials
New tech-enabled services empower pharmaceutical companies to optimize biospecimen operations and data management, transforming sample data into actionable insights RICHMOND,...
IntegriChain and Federal Compliance Solutions Experts to Speak on the Intricacies Inflation Reduction Act at MDRP Summit
PHILADELPHIA, Sept. 10, 2024 /PRNewswire/ -- IntegriChain, the leading provider of pharma revenue optimization technology and insights for the pharmaceutical industry,...
Purisys Activates Drug Master File for Nalmefene, Introducing New Solution for Acute Opioid Overdose Treatment
Athens, Georgia--(Newsfile Corp. - September 10, 2024) - Purisys LLC, a leading supplier of active pharmaceutical ingredients (APIs), contract development...
Jones Healthcare Group Partners with GDK Marketing to Strengthen Presence in Quebec’s Pharmacy Market
New Partnership Enhances Jones Healthcare Group's Reach in Quebec with Local Expertise and French-Language SupportLondon, Ontario--(Newsfile Corp. - September 10,...
Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial of Soquelitinib for Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma
Soquelitinib is a potential first-in-class ITK inhibitor with broad potential in cancer and immune diseases There are currently no fully...
Danam Health, Inc. Announces Acquisition of Wellgistics, LLC
Tampa, FL, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Danam Health, Inc. (“Danam”) today announced that it completed its acquisition of...
New Secondary Analysis of Phase 3 Data Demonstrates Sotagliflozin Improves Time-In-Range (TIR) and Several Parameters of Glucose Control and Variability in Basal Insulin-Treated Type 2 Diabetes
Study results aligned with positive clinical trial outcomes for type 1 diabetes treatment with sotagliflozin TIR measures approach target set...
A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies’ access efforts are
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The latest report from the Access to Medicine Foundation takes a first-ever look...
Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024
SAN DIEGO, CA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma,” “Connect” or the...
Korro to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing...
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and...
ViaDerma Completes First Shipment of 500,000 Units to Nigeria
A second shipment of 500,000 units is expected to be made by the end of OctoberLOS ANGELES, Sept. 10, 2024...